A Case of Malignant Pleural Mesothelioma with Spermatic Cord and Peritoneal Involvement That Responded to Ipilimumab+Nivolumab Combination Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Case of Malignant Pleural Mesothelioma with Spermatic Cord and Peritoneal Involvement That Responded to Ipilimumab+Nivolumab Combination Therapy

Published:2023-10-20 Issue:6 Volume:63 Page:887-891
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Tsuruga Tatsuki¹,Fujimoto Hajime¹,Esumi Seiya¹,Esumi Maki¹,Tsuji Chikashi¹,Yagi Akihiko¹,Okano Tomohito¹,Tomaru Atsushi¹,Kobayashi Tetsu¹,Asayama Kentarou²

Affiliation:

1. Department of Respiratory Medicine, Mie University School of Medicine Hospital

2. Department of Respiratory Medicine, Suzuka General Hospital

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/63/6/63_887/_pdf

Reference14 articles.

1. 1. 日本肺癌学会, 編集. 肺癌診療ガイドライン2022年版. 東京: 金原出版; 2022: 346-347.

2. 2. Ahmed Z, Singh S, Mangal A, Mittal A. Primary malignant mesothelioma of the spermatic cord. BMJ Case Rep. 2016; 2016: bcr2016214602.

3. 3. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-asbestos causes. Arch Pathol Lab Med. 2018; 142: 753-760.

4. 4. Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Transl Lung Cancer Res. 2020; 9 (Suppl 1): S47-S59.

5. 5. Trassl L, Stathopoulos GT. KRAS pathway alterations in malignant pleural mesothelioma: An underestimated player. Cancers. 2022; 14: 4303.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP